StonvexLoading…
StonvexStonvexStonvexCore line items from NVGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $538.46M | $511.67M | $493.34M | $405.35M |
Operating Income | $165.43M | $143.18M | $137.17M | $60.66M |
Net Income | $100.12M | $85.57M | $82.25M | $53.47M |
EPS (Diluted) | $1.47 | $1.19 | $1.10 | $0.69 |
Total Assets | $2.28B | $2.18B | $2.20B | $2.10B |
Total Liabilities | $1.02B | $934.26M | $969.61M | $923.33M |
Cash & Equivalents | $154.95M | $130.82M | $149.60M | $146.67M |
Free Cash Flow OCF − CapEx | $116.64M | $210.52M | $-17.31M | $84.59M |
Shares Outstanding | 65.25M | 69.40M | 73.21M | 76.80M |